Zeltiq Aesthetics Inc. (ZLTQ) Insider Mark J. Foley Sells 10,000 Shares

Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) insider Mark J. Foley sold 10,000 shares of the company’s stock in a transaction dated Monday, November 14th. The stock was sold at an average price of $39.54, for a total transaction of $395,400.00. Following the transaction, the insider now owns 261,941 shares in the company, valued at approximately $10,357,147.14. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) traded up 0.84% during mid-day trading on Wednesday, reaching $40.72. The company had a trading volume of 74,219 shares. The firm’s 50-day moving average is $37.67 and its 200-day moving average is $33.57. The firm has a market capitalization of $1.63 billion, a P/E ratio of 52.54 and a beta of 0.89. Zeltiq Aesthetics Inc. has a one year low of $18.41 and a one year high of $41.48.

Zeltiq Aesthetics (NASDAQ:ZLTQ) last released its earnings results on Wednesday, November 9th. The company reported $0.12 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.08 by $0.04. Zeltiq Aesthetics had a negative return on equity of 6.45% and a net margin of 9.48%. The firm had revenue of $95.20 million for the quarter, compared to analysts’ expectations of $90.84 million. During the same quarter in the previous year, the business posted $0.05 earnings per share. The business’s revenue for the quarter was up 55.6% on a year-over-year basis. On average, equities research analysts anticipate that Zeltiq Aesthetics Inc. will post ($0.08) earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for Zeltiq Aesthetics (NASDAQ:ZLTQ)

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Credit Suisse AG boosted its position in Zeltiq Aesthetics by 500.1% in the third quarter. Credit Suisse AG now owns 228,645 shares of the company’s stock worth $8,968,000 after buying an additional 190,545 shares in the last quarter. Symmetry Peak Management LLC purchased a new stake in shares of Zeltiq Aesthetics during the third quarter worth approximately $294,000. D. E. Shaw & Co. Inc. raised its stake in shares of Zeltiq Aesthetics by 102.2% in the third quarter. D. E. Shaw & Co. Inc. now owns 54,507 shares of the company’s stock worth $2,138,000 after buying an additional 27,551 shares during the last quarter. The Manufacturers Life Insurance Company purchased a new stake in shares of Zeltiq Aesthetics during the third quarter worth approximately $945,000. Finally, Two Sigma Advisers LP purchased a new stake in shares of Zeltiq Aesthetics during the third quarter worth approximately $1,664,000.

A number of research firms have issued reports on ZLTQ. Canaccord Genuity upped their target price on shares of Zeltiq Aesthetics from $41.00 to $45.00 and gave the company a “buy” rating in a research report on Thursday, November 10th. Maxim Group upped their target price on shares of Zeltiq Aesthetics from $40.00 to $48.00 and gave the company a “buy” rating in a research report on Tuesday, August 9th. Zacks Investment Research downgraded shares of Zeltiq Aesthetics from a “strong-buy” rating to a “hold” rating in a research report on Saturday. Northcoast Research restated a “buy” rating on shares of Zeltiq Aesthetics in a research report on Tuesday, November 8th. Finally, Brean Capital set a $39.00 target price on shares of Zeltiq Aesthetics and gave the company a “buy” rating in a research report on Tuesday, August 9th. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Zeltiq Aesthetics has an average rating of “Buy” and an average target price of $42.78.

Zeltiq Aesthetics Company Profile

ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.

5 Day Chart for NASDAQ:ZLTQ

Receive News & Ratings for Zeltiq Aesthetics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zeltiq Aesthetics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2016 Mideast Time.